E. Liberopoulos

Publications196
h-index39
Citations4,809
Highly Influential Citations123
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • M. Elisaf
  • 628 Publications, 17,051 Citations
  • D. Mikhailidis
  • 1,286 Publications, 35,571 Citations
  • G. Watts
  • 949 Publications, 34,121 Citations
  • V. Athyros
  • 449 Publications, 10,094 Citations
  • Publications
  • Influence
Diabetes mellitus and electrolyte disorders.
Diabetic patients frequently develop a constellation of electrolyte disorders. These disturbances are particularly common in decompensated diabetics, especially in the context of diabetic… Expand
  • 149
  • 14
Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study
ABSTRACT Background: Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic syndrome (MetS). There is no established treatment for NAFLD. Aim: To evaluate a… Expand
  • 215
  • 8
"European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses.
Aim of the present Consensus Statement is to provide a comprehensive and up to-date document on the pathophysiology, atherogenicity and clinical significance of low density liproproteins (LDL)… Expand
  • 167
  • 6
Multiple actions of high-density lipoprotein
  • 78
  • 5
The role of C-reactive protein in atherosclerotic cardiovascular disease: an overview.
C-reactive protein (CRP) is an acute-phase protein, which has been used in clinical practice as a non specific marker of inflammation. Many studies have shown that CRP is associated with… Expand
  • 53
  • 5
Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander?
Elevated serum uric acid (SUA) levels are commonly seen in patients with the metabolic syndrome (MetS). Several mechanisms, both direct and indirect, connect the increased SUA levels with the… Expand
  • 227
  • 4
The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An…
Non-alcoholic fatty liver disease (NAFLD), the most common liver disease, is characterized by accumulation of fat (>5% of the liver tissue), in the absence of alcohol abuse or other chronic liver… Expand
  • 111
  • 4
Association of Drinking Pattern and Alcohol Beverage Type With the Prevalence of Metabolic Syndrome, Diabetes, Coronary Heart Disease, Stroke, and Peripheral Arterial Disease in a Mediterranean Cohort
The purpose of this study was to investigate the relationship between alcohol consumption and the prevalence of the metabolic syndrome (MetS), type 2 diabetes mellitus (DM), coronary heart disease… Expand
  • 132
  • 4
Spurious Electrolyte Disorders: A Diagnostic Challenge for Clinicians
Spurious electrolyte disorders refer to an artifactually elevated or decreased serum electrolyte values that do not correspond to their actual systemic levels. When a clinician is confronted with a… Expand
  • 52
  • 4
Novel roles of vitamin D in disease: what is new in 2011?
Vitamin D is a steroid molecule, mainly produced in the skin that regulates the expression of a large number of genes. Until recently its main known role was to control bone metabolism and calcium… Expand
  • 90
  • 3